What is Spiriplex?
Spiriplex is dedicated to improving health outcomes for individuals suffering from allergies and asthma. The company leverages scientific literature and research to provide valuable information and resources, empowering clients to manage their conditions more effectively. By focusing on reliable information and solutions, Spiriplex aims to be a key resource for those seeking better health management strategies for respiratory and allergic ailments.
How much funding has Spiriplex raised?
Spiriplex has raised a total of $99K across 1 funding round:
Debt
$99K
Debt (2021): $99K with participation from PPP
What's next for Spiriplex?
With substantial expansion capital secured, Spiriplex is poised for significant growth. This investment will likely fuel further research and development initiatives, potentially expanding their service offerings or deepening their scientific inquiry into allergy and asthma management. The company's strategic focus on evidence-based solutions suggests a trajectory aimed at solidifying its position as a trusted authority in the health-tech space, particularly for respiratory and allergic conditions.
See full Spiriplex company page
